Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Shareholders??? Deficit (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes In Shareholders’ Deficit (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 116,750 $ 37,266,328 $ (40,000,015) $ (2,616,937)
Balance (in Shares) at Dec. 31, 2019 116,749,633      
Shares issued for conversion of accounts payable $ 151 5,907   6,058
Shares issued for conversion of accounts payable (in Shares) 151,456      
Common shares issued for cash $ 7,000 273,000   280,000
Common shares issued for cash (in Shares) 7,000,000      
Common shares issued for conversion of accrued interest $ 475 12,245   12,720
Common shares issued for conversion of accrued interest (in Shares) 475,000      
Common shares issued for services $ 1,250 48,750   50,000
Common shares issued for services (in Shares) 1,250,000      
Issuance of warrants in connection with convertible debt   8,676   8,676
Accretion of stock-based compensation   170,072   170,072
Accretion of stock option expense   191,308   191,308
Net loss     (1,508,288) (1,508,288)
Balance at Mar. 31, 2020 $ 125,626 37,976,286 (41,508,303) (3,406,391)
Balance (in Shares) at Mar. 31, 2020 125,626,089      
Balance at Dec. 31, 2020 $ 228,347 42,573,272 (45,968,839) (3,167,220)
Balance (in Shares) at Dec. 31, 2020 228,346,974      
Common shares issued for stock-based compensation $ 2,700 (2,700)    
Common shares issued for stock-based compensation (in Shares) 2,700,000      
Beneficial conversion charge for issuance of Series B preferred shares for accrued compensation recorded as stock-based compensation   3,778,810   3,778,810
Common shares issued for accrued compensation $ 945 54,796   55,741
Common shares issued for accrued compensation (in Shares) 944,767      
Accretion of stock-based compensation   108,554   108,554
Accretion of stock-based professional fees   5,000   5,000
Common shares issued for professional fees $ 1,550 112,550   114,100
Common shares issued for professional fees (in Shares) 1,550,000      
Common shares issued for cashless warrant exercise $ 1,008 (1,008)    
Common shares issued for cashless warrant exercise (in Shares) 1,008,000      
Preferred stock dividends and deemed dividend   2,845,238 (2,855,576) (10,338)
Net loss     (4,863,973) (4,863,973)
Balance at Mar. 31, 2021 $ 234,550 $ 49,474,512 $ (53,688,388) $ (3,979,326)
Balance (in Shares) at Mar. 31, 2021 234,549,741